MediPharm Labs Corp. (TSX:LABS)
Canada · Delayed Price · Currency is CAD 0.0800
0.00 (0.00%)
Aug 28, 2026, 9:52 AM EST
MediPharm Labs Financials Overview
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 41.46 | 45.12 | 41.96 | 33.06 | 22.12 | 21.71 |
Revenue Growth | -6.74% | 7.54% | 26.92% | 49.49% | 1.87% | -39.71% |
Gross Profit Gross Profit Growth | 13.14 | 13.86 | 12.69 | 8.1 | -2.07 | -13.42 |
Operating Income Operating Income Growth | -3.94 | -7.22 | -9.94 | -13.32 | -27.77 | -45.72 |
Net Income Net Income Growth | -4.97 | -8.27 | -10.69 | -13.08 | -29.98 | -54.8 |
Earnings Per Share EPS Growth | -0.01 | -0.02 | -0.03 | -0.04 | -0.11 | -0.22 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Canada Canada Growth | 18.57 | 19.76 | 24.15 | 23.09 | 14.69 | 12.22 |
Australia Australia Growth | 7.47 | 10.72 | 8.83 | 5.39 | 2.61 | 4.3 |
Germany Germany Growth | 12.35 | 12.01 | 8.58 | 3.58 | 3.65 | 5.15 |
Other Other Growth | 3.07 | 2.64 | 0.41 | 1.01 | 1.17 | 0.04 |
Total Total Growth | 41.46 | 45.12 | 41.96 | 33.06 | 22.12 | 21.71 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 10.42 | 11.37 | 11.88 | 18.25 | 24.9 | 35.25 |
Total Debt Total Debt Growth | 0.42 | 0.2 | 0.39 | 2.3 | 0.63 | 0.22 |
Net Cash (Debt) Net Cash Growth | 10 | 11.17 | 11.49 | 15.95 | 24.27 | 35.04 |
Net Cash Growth | -1.01% | -2.79% | -27.99% | -34.27% | -30.73% | 897.86% |
Net Cash Per Share Net Cash Per Share Growth | 0.02 | 0.03 | 0.03 | 0.04 | 0.09 | 0.14 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -0.98 | -5.5 | -4.86 | -12.34 | -16.07 | -13.21 |
Capital Expenditures CapEx Growth | -0.06 | -0.1 | -0.15 | -0.47 | -0.86 | -0.78 |
Free Cash Flow Free Cash Flow Growth | -1.04 | -5.6 | -5.02 | -12.81 | -16.93 | -14 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.70% | 30.71% | 30.24% | 24.50% | -9.38% | -61.81% |
Operating Margin | -9.51% | -16.00% | -23.68% | -40.30% | -125.56% | -210.59% |
Pretax Margin | -12.00% | -18.32% | -25.49% | -40.41% | -135.59% | -251.89% |
Profit Margin | -12.00% | -18.32% | -25.49% | -39.57% | -135.56% | -252.41% |
FCF Margin | -2.52% | -12.42% | -11.95% | -38.75% | -76.56% | -64.46% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 22.71 | 22.71 | 22.71 | 22.71 | 22.71 |
PS Ratio | 0.82 | 0.61 | 0.59 | 0.79 | 0.89 | 2.31 |